
European Journal of Medicinal Chemistry p. 321 - 326 (1995)
Update date:2022-09-26
Topics:
Komiotis, D.
Pananookooln, S.
Zaw, K.
Dieter, J. P.
Breton, G. C. Le
Venton, D. L.
The title compounds have been synthesized and their in vitro thromboxane A2(TxA2) receptor antagonist activity evaluated.Both cis and trans isomers (1,2) were shown to specifically inhibit submaximal human platelet aggregation induced by 225 nM U46619 in a dose-dependent manner with an IC50 of 1 μM.The concentration of 1 and 2 required to completely block maximal aggregation induced by 3 μM U46619 was 3 μM. thromboxane A2/ receptor antagonist/ platelet aggregation/ 1,3-dioxolane
View MoreLuoyang Aoda chemical Co.,Ltd.
Contact:+86-379-67518785 67516588
Address:MiaoWan industry district,YanShi City,Henan,China
Wuhan Shangrisyn chemicals Technology Co.,Ltd(expird)
Contact:+86-027-84466317 __ +86-15387123698
Address:wuhan - china
website:http://www.maisonchem.com.cn
Contact:0086-311-83833777
Address:Leitou industrial district, xinji, shijiazhuang city, hebei province,
Jiangsu Feymer Technology Co., Ltd.
Contact:+86-512-58110132
Address:Fenghuang Town, Zhangjiagang City, Jiangsu Province, China
Shandong Xinhua Pharmaceutical Co.,Ltd
website:http://www.xhzy.com
Contact:+86-533-2196801
Address:1 lutai road,zhangdian dis,Zibo City
Doi:10.1016/S0040-4039(00)85246-6
(1986)Doi:10.1039/c39900000897
(1990)Doi:10.1039/c2ob06934b
(2012)Doi:10.1007/BF00487436
(1990)Doi:10.1021/ol2011067
(2011)Doi:10.1016/0022-328X(86)82021-6
(1986)